Sevoflurane Inhibits Invasion and Migration of Lung Cancer Cells by Inactivating the P38 MAPK Signaling Pathway

Overview

Journal J Anesth

Specialty Anesthesiology

Date 2012 Feb 22

PMID 22349744

Citations 42

Authors

Hua Liang

Miaoning Gu

Chengxiang Yang

Hanbing Wang

Xianjie Wen

Qiaoling Zhou

Affiliations

Soon will be listed here.

Abstract

Purpose: Sevoflurane is used widely during lung cancer surgery. However, the effect of sevoflurane on the invasion and migration of lung carcinoma cells remains unclear. The aims of this study were to explore the role of matrix metalloproteinase (MMP)-2 and MMP-9 in the effect of sevofluane on the invasion and the role of fascin and ezrin on the effect of sevofluane on the migration of human lung adenocarcinoma A549 cells. We also investigated whether sevoflurane regulates the expression of these molecules through the p38 mitogen-activated protein kinase (MAPK) signaling pathway.

Methods: The invasion of cells was evaluated using the Transwell invasion assay, and the migration of cells was determined using the wound healing assay. The expression of MMP-2, MMP-9, ezrin, fascin, and phospho-p38 MAPK in cells was determined by western blotting.

Results: A significant inhibition of cell invasion and migration was found in A549 cells which had been treated with sevoflurane. The data also revealed that sevoflurane could decrease the phosphorylation level of p38 MAPK, which is involved in the downregulation of MMP-2, MMP-9, fascin, and ezrin expression, accompanied by a concomitant inhibition of the invasion and migration of A549 cells. SB203580, a p38 MAPK inhibitor, augmented the downregulation of the expression of these proteins.

Conclusion: The anti-invasion effect of sevoflurane on A549 cells was associated with a downregulation of both MMP-2 and MMP-9 expression, while the anti-migration effect was associated with a downregulation of both fascin and ezrin expression. These effects could occur partly as a result of inactivation of the p38 MAPK signaling pathway.

Citing Articles

Anesthetic Approaches and Their Impact on Cancer Recurrence and Metastasis: A Comprehensive Review.

Choi H, Hwang W Cancers (Basel). 2025; 16(24.

PMID: 39766169 PMC: 11674873. DOI: 10.3390/cancers16244269.

The Role of Anesthetic Management in Lung Cancer Recurrence and Metastasis: A Comprehensive Review.

Huh J, Hwang W J Clin Med. 2024; 13(22).

PMID: 39597826 PMC: 11594908. DOI: 10.3390/jcm13226681.

Effects of anesthesia on long-term survival in cancer surgery: A systematic review and meta-analysis.

Tang Y, Tang L, Yao Y, Huang H, Chen B Heliyon. 2024; 10(3):e24791.

PMID: 38318020 PMC: 10839594. DOI: 10.1016/j.heliyon.2024.e24791.

Effect of Sevoflurane on the Proliferation of A549 Lung Cancer Cells.

Yun S, Kim K, Shin K, Park H, Lee S, Shin Y Medicina (Kaunas). 2023; 59(3).

PMID: 36984614 PMC: 10054785. DOI: 10.3390/medicina59030613.

Dezocine inhibits cell proliferation, migration, and invasion by targeting CRABP2 in ovarian cancer.

Zhang C, Pan R, Ma S, Xu S, Wang B Open Med (Wars). 2022; 17(1):2052-2061.

PMID: 36568517 PMC: 9755696. DOI: 10.1515/med-2022-0541.

References

Coffey J, Wang J, Smith M, Bouchier-Hayes D, Cotter T, Redmond H . Excisional surgery for cancer cure: therapy at a cost. Lancet Oncol. 2003; 4(12):760-8. DOI: 10.1016/s1470-2045(03)01282-8. View

Ma L, Liu Y, Geng C, Xing L, Zhang X . Low-dose epirubicin inhibits ezrin-mediated metastatic behavior of breast cancer cells. Tumori. 2011; 97(3):400-5. DOI: 10.1177/030089161109700324. View

Dhanasekaran D, Johnson G . MAPKs: function, regulation, role in cancer and therapeutic targeting. Oncogene. 2007; 26(22):3097-9. DOI: 10.1038/sj.onc.1210395. View

Iniesta P, Moran A, De Juan C, Gomez A, Hernando F, Garcia-Aranda C . Biological and clinical significance of MMP-2, MMP-9, TIMP-1 and TIMP-2 in non-small cell lung cancer. Oncol Rep. 2006; 17(1):217-23. View

Hashimoto Y, Skacel M, Adams J . Roles of fascin in human carcinoma motility and signaling: prospects for a novel biomarker?. Int J Biochem Cell Biol. 2005; 37(9):1787-804. DOI: 10.1016/j.biocel.2005.05.004. View

Hunter K . Ezrin, a key component in tumor metastasis. Trends Mol Med. 2004; 10(5):201-4. DOI: 10.1016/j.molmed.2004.03.001. View

Yoder B, Tso E, Skacel M, Pettay J, Tarr S, Budd T . The expression of fascin, an actin-bundling motility protein, correlates with hormone receptor-negative breast cancer and a more aggressive clinical course. Clin Cancer Res. 2005; 11(1):186-92. View

Kvolik S, Dobrosevic B, Marczi S, Prlic L, Glavas-Obrovac L . Different apoptosis ratios and gene expressions in two human cell lines after sevoflurane anaesthesia. Acta Anaesthesiol Scand. 2009; 53(9):1192-9. DOI: 10.1111/j.1399-6576.2009.02036.x. View

Hashimoto Y, Skacel M, Lavery I, Mukherjee A, Casey G, Adams J . Prognostic significance of fascin expression in advanced colorectal cancer: an immunohistochemical study of colorectal adenomas and adenocarcinomas. BMC Cancer. 2006; 6:241. PMC: 1615879. DOI: 10.1186/1471-2407-6-241. View

10.

Chetty C, Rao J, Lakka S . Matrix metalloproteinase pharmacogenomics in non-small-cell lung carcinoma. Pharmacogenomics. 2011; 12(4):535-46. DOI: 10.2217/pgs.10.207. View

11.

Loop T, Scheiermann P, Doviakue D, Musshoff F, Humar M, Roesslein M . Sevoflurane inhibits phorbol-myristate-acetate-induced activator protein-1 activation in human T lymphocytes in vitro: potential role of the p38-stress kinase pathway. Anesthesiology. 2004; 101(3):710-21. DOI: 10.1097/00000542-200409000-00020. View

12.

Roesslein M, Frick M, Auwaerter V, Humar M, Goebel U, Schwer C . Sevoflurane-mediated activation of p38-mitogen-activated stresskinase is independent of apoptosis in Jurkat T-cells. Anesth Analg. 2008; 106(4):1150-60, table of contents. DOI: 10.1213/ane.0b013e3181683d37. View

13.

Friedl P, Wolf K . Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer. 2003; 3(5):362-74. DOI: 10.1038/nrc1075. View

14.

Ludwig C, Stoelben E, Olschewski M, Hasse J . Comparison of morbidity, 30-day mortality, and long-term survival after pneumonectomy and sleeve lobectomy for non-small cell lung carcinoma. Ann Thorac Surg. 2005; 79(3):968-73. DOI: 10.1016/j.athoracsur.2004.08.062. View

15.

Jayo A, Parsons M . Fascin: a key regulator of cytoskeletal dynamics. Int J Biochem Cell Biol. 2010; 42(10):1614-7. DOI: 10.1016/j.biocel.2010.06.019. View

16.

Li Q, Wu M, Wang H, Xu G, Zhu T, Zhang Y . Ezrin silencing by small hairpin RNA reverses metastatic behaviors of human breast cancer cells. Cancer Lett. 2007; 261(1):55-63. DOI: 10.1016/j.canlet.2007.11.018. View

17.

Kessenbrock K, Plaks V, Werb Z . Matrix metalloproteinases: regulators of the tumor microenvironment. Cell. 2010; 141(1):52-67. PMC: 2862057. DOI: 10.1016/j.cell.2010.03.015. View

18.

Bruce B, Khanna G, Ren L, Landberg G, Jirstrom K, Powell C . Expression of the cytoskeleton linker protein ezrin in human cancers. Clin Exp Metastasis. 2007; 24(2):69-78. DOI: 10.1007/s10585-006-9050-x. View

19.

Coussens L, Fingleton B, Matrisian L . Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science. 2002; 295(5564):2387-92. DOI: 10.1126/science.1067100. View

20.

Kvolik S, Glavas-Obrovac L, Bares V, Karner I . Effects of inhalation anesthetics halothane, sevoflurane, and isoflurane on human cell lines. Life Sci. 2005; 77(19):2369-83. DOI: 10.1016/j.lfs.2004.12.052. View